For the Inventor, By the Inventor

Enter assignee name

Parsippany, NJ, United States of America

Auspex Pharmaceuticals, Inc.

USPTO Granted Patents = 73

CIPO Patents = 2

EPO Patents = 17

Trademarks = 5

Forward Citations = 325

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Chengzhi Zhang (37 out of 59 patents)

Thomas George Gant (28 out of 30 patents)

Sepehr Sarshar (26 out of 34 patents)

4. Tadimeti Rao (14 out of 14 patents)

5. Andreas Sommer (9 out of 9 patents)

6. John Charles Arthur (9 out of 9 patents)

7. John Carter (9 out of 17 patents)

8. Margaret Bradbury (9 out of 9 patents)

9. Manouchehr Shahbaz (8 out of 8 patents)

10. David Stamler (6 out of 6 patents)

11. Michael Huang (6 out of 9 patents)

12. Subramanian Marappan (2 out of 18 patents)

13. James Kerr (2 out of 2 patents)

14. Justin Chakma (2 out of 2 patents)

15. Bruno Tse (2 out of 11 patents)

Core Competencies:

Benzoquinoline Compounds

Deutetrabenazine

Vesicular Monoamine Transporter 2

Dyskinesia Treatment

Cystic Fibrosis Modulators

Tyrosine Kinase Inhibitors

Serotoninergic Activity

Janus Kinase 3 Inhibitors

Beta-3-Adrenoreceptor Modulators

P2Y12 Receptor Modulators

Pharmacokinetics

Lipoproten-Associated Phospholipase A2 Inhibitors

73 patents: Sort by Forward Citations

1. 12077487 - Methods of manufacturing benzoquinoline compounds (2024-09-03),

2. 12016858 - Methods for the treatment of abnormal involuntary movement disorders (2024-06-25),

3. 11813232 - Analogs of deutetrabenazine, their preparation and use (2023-11-14),

4. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2023-06-06),

5. 11648244 - Methods for the treatment of abnormal involuntary movement disorders (2023-05-16),

6. 11564917 - Methods for the treatment of abnormal involuntary movement disorders (2023-01-31),

7. 11446291 - Methods for the treatment of abnormal involuntary movement disorders (2022-09-20),

8. 11357772 - Methods for the treatment of abnormal involuntary movement disorders (2022-06-14),

9. 11324732 - Methods for the treatment of dyskinesia in cerebral palsy (2022-05-10),

10. 11311488 - Osmotic dosage forms comprising deutetrabenazine and methods of use thereof (2022-04-26),

11. 11179386 - Analogs of deutetrabenazine, their preparation and use (2021-11-23),

12. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2021-06-15),

13. 10966922 - Pharmaceutical formulations (2021-04-06),

14. 10959996 - Methods for the treatment of abnormal involuntary movement disorders (2021-03-30),

15. 10722479 - Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2 (2020-07-28),

AusPex Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative medicines for the treatment of neurologic and neurodegenerative diseases. With a special emphasis on movement disorders and orphan diseases, AusPex is dedicated to improving the lives of patients and their families. Combining scientific expertise, advanced technology, and a patient-centric approach, AusPex aims to deliver novel therapies that address significant unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

73 Patents

#10 in Parsippany, NJ

#222 in New Jersey

#4,849 in US

#9,950 in the World

Parsippany, NJ, United States of America

Auspex Pharmaceuticals, Inc.

Forward Citations = 325

32 inventors:

Chengzhi Zhang (37 out of 59 patents)

Thomas George Gant (28 out of 30 patents)

Sepehr Sarshar (26 out of 34 patents)

4. Tadimeti Rao (14 out of 14 patents)

5. Andreas Sommer (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…